Description
A TRPV1 antagonist (IC50 = 0.9 nM); inhibits mechanical and thermal allodynia in a rat model of burn injury at 165 µg, intrathecally; reverses increases in the level of CGRP and increases expression of GFAP and GAP-43 in the dorsal horn of the spinal cord, as well as enhances axonal regeneration in a rat model of sciatic nerve transection injury
Formal name: N-[4-[[6-[4-(trifluoromethyl)phenyl]-4-pyrimidinyl]oxy]-2-benzothiazolyl]-acetamide
Synonyms:
Molecular weight: 430.4
CAS: 659730-32-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ion Channel Modulation|Blockers||Research Area|Neuroscience|Pain Research